L Hammar|S Eriksson|B Morein - JoVE Visualize

Showing results (81-90 of 921) with videos related to

Pageof 93

Sort By:

Vaccine|December 31, 1997

Effects of carbohydrate modification of Quillaja saponaria Molina QH-B fraction on adjuvant activity, cholesterol-binding capacity and toxicityB Rönnberg, M Fekadu, S Behboudi, et al.

Cellular Immunology|September 1, 1990

Effect of iscoms and their adjuvant moiety (matrix) on the initial proliferation and IL-2 responses: comparison of spleen cells from mice inoculated with iscoms and/or matrixC Fossum, M Bergström, K Lövgren, et al.

Medical Microbiology and Immunology|January 1, 1987

Monocyte and iscom enhancement of cell-mediated response to cytomegalovirusB Wahren, S Nordlund, A Akesson, et al.

FEMS Immunology and Medical Microbiology|September 11, 2001

Different respiratory syncytial virus and Quillaja saponin formulations induce murine peritoneal cells to express different proinflammatory cytokine profilesK F Hu, M Chen, I Abusugra, et al.

Scandinavian Journal of Immunology|October 1, 1992

Antigen-specific increases in the number of splenocytes expressing MHC class II molecules following restimulation with antigen in various physical formsM Bergström-Mollaoglu, K Lövgren, L Akerblom, et al.

Philosophical Transactions. Series A, Mathematical, Physical, and Engineering Sciences|February 21, 2018

Precision measurements on trapped antihydrogen in the ALPHA experimentS Eriksson

Acta Medica Scandinavica|January 1, 1987

Alpha 1-antitrypsin deficiency and liver cirrhosis in adults. An analysis of 35 Swedish autopsied casesS Eriksson

Schweizerische Medizinische Wochenschrift|June 23, 1984

Alpha 1-antitrypsin deficiency: some personal experiencesS Eriksson

Annals of Clinical Research|April 1, 1983

The effect of tamoxifen in intermediate alpha 1-antitrypsin deficiency associated with the phenotype PiSZS Eriksson

European Journal of Immunology|November 1, 1988

In vitro T cell responses to a candidate Epstein-Barr virus vaccine: human CD4+ T cell clones specific for the major envelope glycoprotein gp340D Ulaeto, L Wallace, A Morgan, et al.

Pageof 93

Showing results (81-90 of 921) with videos related to

Sort By:

Pageof 93

Vaccine|December 31, 1997

Effects of carbohydrate modification of Quillaja saponaria Molina QH-B fraction on adjuvant activity, cholesterol-binding capacity and toxicityB Rönnberg, M Fekadu, S Behboudi, et al.

Cellular Immunology|September 1, 1990

Effect of iscoms and their adjuvant moiety (matrix) on the initial proliferation and IL-2 responses: comparison of spleen cells from mice inoculated with iscoms and/or matrixC Fossum, M Bergström, K Lövgren, et al.

Medical Microbiology and Immunology|January 1, 1987

Monocyte and iscom enhancement of cell-mediated response to cytomegalovirusB Wahren, S Nordlund, A Akesson, et al.

FEMS Immunology and Medical Microbiology|September 11, 2001

Different respiratory syncytial virus and Quillaja saponin formulations induce murine peritoneal cells to express different proinflammatory cytokine profilesK F Hu, M Chen, I Abusugra, et al.

Scandinavian Journal of Immunology|October 1, 1992

Antigen-specific increases in the number of splenocytes expressing MHC class II molecules following restimulation with antigen in various physical formsM Bergström-Mollaoglu, K Lövgren, L Akerblom, et al.

Philosophical Transactions. Series A, Mathematical, Physical, and Engineering Sciences|February 21, 2018

Precision measurements on trapped antihydrogen in the ALPHA experimentS Eriksson

Acta Medica Scandinavica|January 1, 1987

Alpha 1-antitrypsin deficiency and liver cirrhosis in adults. An analysis of 35 Swedish autopsied casesS Eriksson

Schweizerische Medizinische Wochenschrift|June 23, 1984

Alpha 1-antitrypsin deficiency: some personal experiencesS Eriksson

Annals of Clinical Research|April 1, 1983

The effect of tamoxifen in intermediate alpha 1-antitrypsin deficiency associated with the phenotype PiSZS Eriksson

European Journal of Immunology|November 1, 1988

In vitro T cell responses to a candidate Epstein-Barr virus vaccine: human CD4+ T cell clones specific for the major envelope glycoprotein gp340D Ulaeto, L Wallace, A Morgan, et al.

Pageof 93